In a recent study, Chen et al. analyzed HJURP mRNA expression and associated clinical parameters in 480 lung adenocarcinoma (LUAD) patients from the TCGA database, and suggested that high HJURP expression may be an independent prognostic factor and a potentially useful prognostic molecular biomarker for low survival in LUAD cases. The gene discussed is HJURP; the disease is lung adenocarcinoma.